Emvose M 0.3 Tablet
Prescription Required
Introduction of Emvose M Tablet
Emvose M 0.3 Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Emvose M 0.3 Tablet is a medicine used in the treatment of type 2 diabetes mellitus. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. When used along with a proper diet and regular exercise, this medicine helps to prevent the long-term complications of diabetes mellitus. It may cause nausea and stomach pain as a side effect, which generally improve with time.
Emvose M 0.3 Tablet is a medicine used in the treatment of type 2 diabetes mellitus. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. When used along with a proper diet and regular exercise, this medicine helps to prevent the long-term complications of diabetes mellitus. It may cause nausea and stomach pain as a side effect, which generally improve with time.
Uses of Emvose M Tablet
Benefits of Emvose M Tablet
In Treatment of Type 2 diabetes mellitus
Emvose M 0.3 Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.
Emvose M 0.3 Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Emvose M 0.3 Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of Emvose M Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Emvose M
- Flatulence
- Diarrhea
- Bloating
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Emvose M Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emvose M 0.3 Tablet is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Emvose M 0.3 Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Emvose M 0.3 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Emvose M 0.3 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Emvose M 0.3 Tablet does not usually affect your ability to drive.
However, patients should be alerted to the risk of hypoglycemia when it is used in combination with other antidiabetic agents such as sulfonylureas, insulin, and repaglinide.
However, patients should be alerted to the risk of hypoglycemia when it is used in combination with other antidiabetic agents such as sulfonylureas, insulin, and repaglinide.
Kidney
CAUTION
Emvose M 0.3 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emvose M 0.3 Tablet may be needed. Please consult your doctor.
Use of Emvose M 0.3 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Use of Emvose M 0.3 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Emvose M 0.3 Tablet in patients with liver disease. Please consult your doctor.
What if you forget to take Emvose M Tablet?
If you miss a dose of Emvose M 0.3 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Emvose M 0.3 Tablet
βΉ6.05/Tablet
Volibo M 0.3 Tablet
Sun Pharmaceutical Industries Ltd
βΉ8.45/tablet
40% costlier
Voglitor MF 0.3 Tablet
Torrent Pharmaceuticals Ltd
βΉ10.99/tablet
82% costlier
Volix M 0.3 Tablet
Sun Pharmaceutical Industries Ltd
βΉ8.45/tablet
40% costlier
Vogo-M 0.3 Tablet
Alembic Pharmaceuticals Ltd
βΉ18.2/tablet
201% costlier
Prandial M 0.3 Tablet
Cipla Ltd
βΉ9.38/tablet
55% costlier
Quick tips
Emvose M Tablet
- Take it with food to lower your chance of having an upset stomach.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.Β
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor, and anxious feeling.
- Monitor your blood sugar level regularly while taking this medicine.
- Tell your doctor immediately if you experience any deep or rapid breathing, persistent nausea, vomiting or stomach pain as Emvose M 0.3 Tablet may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- CiplaMed. Voglibose + Metformin hydrochloride. [Accessed 08 Apr. 2019] (online) Available from:
- Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company. [Accessed 08 Apr. 2019] (online) Available from:
- Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003. [Accessed 08 Apr. 2019] (online) Available from:
- Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 08 Apr. 2019] (online) Available from:
- Metformin hydrochloride and Voglibose (Tablets) [Prescribing information]. Himachal Pradesh, India: Biocon Limited; 2011. [Accessed 21 Oct. 2021] (online) Available from:
Marketer details
Name: Medopharm
Address: 25,Puliyur 2'nd Main Road, Trustpuram, Kodambakkam, Chennai, Tamilnadu, India, Pincode 600024
Country of origin: India
Lab tests offered by us
Related/Popular tests
28 people viewed this recentlyMRP
βΉ60.5
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT